Skip to Main content Skip to Navigation
Poster communications

LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather

H. Fontaine 1 C. Hezode 2 F. Zoulim 3, 4 D. Samuel 4 M. Bourlière 5 G. Haour 6 C. Dorival-Mouly 6 V. Leroy 7 V. de Ledinghen 8, 9 S. Lucier 6 D. Larrey 10, 11 A. Tran 12 S. Metivier 13 Y. Benhamou 14, 15 I. Hubert-Fouchard 16 F. Habersetzer 17, 18 P. Marcellin 19 P. Mathurin 20 Laurent Alric 21, 22 J. -P. Bronowicki 23, 24 D. Guyader 25, 26 V. Loustaud-Ratti 27, 28 A. Minello 29 G. Riachi 30 I. Rosa 31 M. Simony A. Diallo F. Carrat 32, 33 S Pol 34, 35
15 Pathologies biliaires, fibrose et cancer du foie [CHU Saint-Antoine]
CR Saint-Antoine - Centre de Recherche Saint-Antoine
Abstract : Introduction:Real-life results of the Sofosbuvir (SOF)/Simeprevir(SIM) combination have been extensively reported in genotype 1-infected patients but there are few or no data regarding genotype 4-infected patients for the SOF/SIM or the SOF-Daclatasvir (DCV)combinations. In January 2015, more than 3003 patients of theFrench observational cohort ANRS CO22 HEPATHER were given thenew oral antivirals in 32 centers: we report the preliminary resultsof the Sofosbuvir-based combinations with DCV or SIM, with orwithout ribavirin (RBV), in Genotype 4-infected patients.Material and Methods:Demographics, history of liver disease werecollected at entry in the cohort. Clinical, adverse events, andvirological data were collected throughout treatment and post-treatment follow-up.
Document type :
Poster communications
Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01162770
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Thursday, June 11, 2015 - 12:49:44 PM
Last modification on : Friday, December 3, 2021 - 12:13:50 PM

Identifiers

Citation

H. Fontaine, C. Hezode, F. Zoulim, D. Samuel, M. Bourlière, et al.. LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather. The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S278, 2015, ⟨10.1016/S0168-8278(15)30182-3⟩. ⟨hal-01162770⟩

Share

Metrics

Record views

892